117 related articles for article (PubMed ID: 20813208)
21. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
[TBL] [Abstract][Full Text] [Related]
22. Solanum lyratum extract inhibits Helicobacter pylori-mediated apoptosis in human gastric epithelial cells.
Hsu YM; Lai CH; Su CH; Kuo WW; Kuo CL; Hsu CK; Wang CK; Chang CY; Chung JG
Anticancer Res; 2010 Apr; 30(4):1189-93. PubMed ID: 20530426
[TBL] [Abstract][Full Text] [Related]
23. San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells.
Shih YT; Wu DC; Liu CM; Yang YC; Chen IJ; Lo YC
J Ethnopharmacol; 2007 Jul; 112(3):537-44. PubMed ID: 17537603
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
25. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori.
Jain SK; Jangdey MS
Mol Pharm; 2009; 6(1):295-304. PubMed ID: 19093870
[TBL] [Abstract][Full Text] [Related]
26. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
[TBL] [Abstract][Full Text] [Related]
27. Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori.
Umamaheshwari RB; Jain NK
J Control Release; 2004 Sep; 99(1):27-40. PubMed ID: 15342178
[TBL] [Abstract][Full Text] [Related]
28. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
29. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
[TBL] [Abstract][Full Text] [Related]
32. Folate targeted polymeric 'green' nanotherapy for cancer.
Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic delivery system using nano-hydroxyapatite/chitosan bone cement consisting of berberine.
Zou Q; Li Y; Zhang L; Zuo Y; Li J; Li J
J Biomed Mater Res A; 2009 Jun; 89(4):1108-17. PubMed ID: 18767062
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S
J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
[TBL] [Abstract][Full Text] [Related]
35. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
Guo M; Que C; Wang C; Liu X; Yan H; Liu K
Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
[TBL] [Abstract][Full Text] [Related]
37. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors.
Jain A; Jain SK
Eur J Pharm Sci; 2008 Dec; 35(5):404-16. PubMed ID: 18824095
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
[TBL] [Abstract][Full Text] [Related]
39. In vitro inhibition of Helicobacter pylori by Enterococcus faecium GM-1.
Kang JH; Lee MS
Can J Microbiol; 2005 Aug; 51(8):629-36. PubMed ID: 16234861
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
